中国医药科学2024，Vol.14Issue(12)：95-99,174,6.DOI:10.20116/j.issn2095-0616.2024.12.23
某院住院药房2019-2021年口服降血脂药的应用分析
Application analysis of oral hypolipidemic drugs in inpatient pharmacy of a hospital from 2019 to 2021
摘要
Abstract
Objective To analyze the application situation and development trend of oral hypolipidemic drugs in Zhongshan Hospital,Fudan University(Xiamen Branch)(hereinafter referred to as"our hospital")from 2019 to 2021,evaluate the rationality of drug use,and provide reference for clinical rational drug use.Methods The usage data of hypolipidemic drugs in inpatient pharmacy of our hospital from 2019 to 2021 were selected from the hospital information management system(HIS),and the names,specifications,annual total amount of discharged drugs and annual total sales amount of such drugs were obtained.The adult defined daily dose(DDD),frequency of drug daily dose(DDDS)and drug daily cost(DDC)recommended by the World Health Organization(WHO)were statistically analyzed,and the synchronization of drug use was compared by ranking ratio(B/A).Results The average annual growth rate of drug consumption of oral hypolipidemic drugs in inpatient of our hospital from 2019 to 2021 was 8.19％,and the sales volume was relatively stable,showing an upward trend year by year.In them,the use of Statins was dominant,with the highest sales amount for three consecutive years,accounting for the largest proportion,followed by Bette class.In the DDDS ranking,Atorvastatin calcium tablets ranked first for three consecutive years,Fenofibrate capsules increased year by year,and ranked second for three consecutive years,while DDDS of other hypolipidemic drugs was relatively stable and fluctuated slightly.The DDC value of Simvastatin tablets was the highest,while the DDC value of Fenofibrate capsules was lower in three years.From 2019 to 2021,the B/A values of the vast majority of hypolipidemic drugs were close to 1,with a relatively good synchronization rate.Conclusion The use of oral hypolipidemic drugs for inpatients in our hospital from 2019 to 2021 is reasonable,and the selection is in line with the specifications.The types of drugs are relatively stable,and the use of drugs meets the requirements of the specification.关键词
降血脂药/用药频度/用药分析/用药金额/阿托伐他汀钙片Key words
Hypolipidemic drugs/Frequency of drug daily dose/Drug use analysis/Amount of drug consumption/Atorvastatin calcium tablets分类
医药卫生引用本文复制引用
李静,沈赟,陈少壮,范彩云,陈斌霞,陈琪琪,顾芙蓉,刘晓鹭,洪小玲,王永胜..某院住院药房2019-2021年口服降血脂药的应用分析[J].中国医药科学,2024,14(12):95-99,174,6.基金项目
厦门市医工结合指导性项目(3502Z20214ZD2176). （3502Z20214ZD2176）
